In a lipopolysaccharide (LPS)-induced ARDS mouse model, pretreatment with Sch A significantly improved LPS-induced histopathological changes and reduced the levels of IL-1β, IL-6, and TNF-α in bronchoalveolar lavage fluid [53]. Here, IL6 is linked to acute respiratory distress syndrome.